Release of fructose and hexose phosphates from perivascular cells induced by low density lipoprotein and acceleration of protein glycation in vitro

被引:2
作者
Takeda, H
Higashi, T
Nishikawa, T
Sato, Y
Anami, Y
Yano, T
Kasho, M
Kobori, S
Shichiri, M
机构
[1] KUMAMOTO UNIV,SCH MED,DEPT BIOCHEM,KUMAMOTO 860,JAPAN
[2] KUMAMOTO UNIV,SCH MED,DEPT METAB MED,KUMAMOTO 860,JAPAN
关键词
fructose; hexose phosphates; vascular smooth muscle cells; low density lipoproteins; glycation;
D O I
10.1016/0168-8227(95)01197-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated whether low density lipoprotein (LDL) under oxidative stress might induce the release of fructose, glucose-6-phosphate and fructose-6-phosphate from perivascular cells, and also whether these substances might within their accelerate the formation of advanced glycation end products (AGE) from proteins in vitro. When vascular smooth muscle cells were incubated with LDL in Ham's F10 at 37 degrees C for 48 h, release of all these substances was increased dose-dependently by oxidized LDL. Fructose release was increased in a dose-dependent manner by glucose. Indomethacin (20 mu M) significantly (P < 0.01) suppressed the release of fructose (25.4 +/- 15.7% of control) and hexose phosphates (29.4 +/- 4.0) with the inhibition of release of lactate dehydrogenase (35.5 +/- 4.9) as well as probucol, whereas an aldose reductase inhibitor, epalrestat, significantly (P < 0.001) inhibited only the fructose release (0.9 +/- 0.8). Release of fructose and hexose phosphates from vascular endothelial cells was also induced by oxidized LDL. AGE immunoreactivities and AGE-related fluorescence formed from proteins and glucose were significantly increased (P < 0.001) in the presence of small amounts of the cellular glucose metabolites (6.6%) with glucose (93.4%). These data suggest that release of potent AGE initiators, fructose and hexose phosphates, from perivascular cells induced by oxidized LDL may be an important phenomenon for vascular complications.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 19 条
[1]  
ARAKI N, 1992, J BIOL CHEM, V267, P10211
[2]  
Bernt E., 1974, METHOD ENZYMAT AN, P1304
[3]   ADVANCED GLYCOSYLATION PRODUCTS QUENCH NITRIC-OXIDE AND MEDIATE DEFECTIVE ENDOTHELIUM-DEPENDENT VASODILATATION IN EXPERIMENTAL DIABETES [J].
BUCALA, R ;
TRACEY, KJ ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :432-438
[4]  
Buege J A, 1978, Methods Enzymol, V52, P302
[5]   GLYCATION, GLYCOXIDATION, AND CROSS-LINKING OF COLLAGEN BY GLUCOSE - KINETICS, MECHANISMS, AND INHIBITION OF LATE STAGES OF THE MAILLARD REACTION [J].
FU, MX ;
WELLSKNECHT, KJ ;
BLACKLEDGE, JA ;
LYONS, TJ ;
THORPE, SR ;
BAYNES, JW .
DIABETES, 1994, 43 (05) :676-683
[6]   LDL-INDUCED CYTOTOXICITY AND ITS INHIBITION BY HDL IN HUMAN VASCULAR SMOOTH-MUSCLE AND ENDOTHELIAL-CELLS IN CULTURE [J].
HESSLER, JR ;
ROBERTSON, AL ;
CHISOLM, GM .
ATHEROSCLEROSIS, 1979, 32 (03) :213-229
[7]  
KUZUYA M, 1990, BIOCHEM INT, V22, P567
[8]  
Lang G., 1974, Methods of Enzymatic Analysis, V3, P1238
[9]   SERUM HIGH-DENSITY LIPOPROTEIN IN DIABETIC-PATIENTS [J].
LOPESVIRELLA, MFL ;
STONE, PG ;
COLWELL, JA .
DIABETOLOGIA, 1977, 13 (04) :285-291
[10]   IMMUNOHISTOCHEMICAL LOCALIZATION OF ALDOSE REDUCTASE .1. ENZYME-PURIFICATION AND ANTIBODY PREPARATION - LOCALIZATION IN PERIPHERAL-NERVE, ARTERY, AND TESTIS [J].
LUDVIGSON, MA ;
SORENSON, RL .
DIABETES, 1980, 29 (06) :438-449